EI
AMRX icon

EAM Investors’s Amneal Pharmaceuticals AMRX Stock Holding History

EAM Investors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-425,718
Closed -$5.36M – 280
2025
Q4 		$5.36M Buy
+425,718
New +$4.87M 0.6% 56
2023
Q4 		– Sell
-230,271
Closed -$972K – 240
2023
Q3 		$972K Buy
+230,271
New +$859K 0.19% 247
2021
Q2 		– Sell
-259,873
Closed -$1.75M – 310
2021
Q1 		$1.75M Buy
+259,873
New +$1.44M 0.26% 166

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EAM Investors's AMRX Position: Q1 2026 in Review

EAM Investors sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 425,718 shares — an estimated $5.36M sold.

EAM Investors first reported a position in AMRX in Q1 2021 and held it in 3 quarters. The position peaked at $5.36M in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • EAM Investors reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 425,718 Amneal Pharmaceuticals shares in Q1 2026, an estimated $5.36M.
  • EAM Investors first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • EAM Investors's Amneal Pharmaceuticals position peaked at $5.36M in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.